Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
Kezar Life Sciences Cash from Operations (TTM) : -42.03M for March 31, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -42.03M |
| December 31, 2025 | -51.78M |
| September 30, 2025 | -56.64M |
| June 30, 2025 | -64.30M |
| March 31, 2025 | -68.54M |
| December 31, 2024 | -74.21M |
| September 30, 2024 | -76.37M |
| June 30, 2024 | -79.08M |
| March 31, 2024 | -83.65M |
| December 31, 2023 | -81.64M |
| September 30, 2023 | -78.55M |
| June 30, 2023 | -74.70M |
| March 31, 2023 | -66.39M |
| December 31, 2022 | -58.85M |
| September 30, 2022 | -54.04M |
| June 30, 2022 | -47.64M |
| March 31, 2022 | -47.39M |
| Date | Value |
|---|---|
| December 31, 2021 | -42.44M |
| September 30, 2021 | -40.66M |
| June 30, 2021 | -39.96M |
| March 31, 2021 | -37.00M |
| December 31, 2020 | -36.95M |
| September 30, 2020 | -34.85M |
| June 30, 2020 | -33.86M |
| March 31, 2020 | -31.48M |
| December 31, 2019 | -29.88M |
| September 30, 2019 | -28.14M |
| June 30, 2019 | -24.49M |
| March 31, 2019 | -23.73M |
| December 31, 2018 | -20.79M |
| September 30, 2018 | -16.94M |
| June 30, 2018 | -14.51M |
| March 31, 2018 | -9.863M |
| December 31, 2017 | -8.109M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| NovelStem International Corp. | -0.2295M |
| Brainstorm Cell Therapeutics, Inc. | -4.057M |
| Summit Therapeutics, Inc. | -457.02M |
| Protara Therapeutics, Inc. | -66.13M |
| Clene, Inc. | -15.96M |